Please use this identifier to cite or link to this item:
Title: Balanço da estratégia de desenvolvimento da biotecnologia farmacêutica no Brasil: 2009-2019
Authors: Meirelles, Beatriz Barbosa
Pimentel, Vitor Paiva
Cruz, Adriana Inhudes Gonçalves da
Reis, Carla
Banco Nacional de Desenvolvimento Econômico e Social (Brasil). Gabinete da Presidência. Departamento de Divulgação. Gerência de Editoração
Keywords: Banco Nacional de Desenvolvimento Econômico e Social (Brasil) - Financiamento
Brazilian Development Bank - Financing
BNDES Funtec
BNDES Profarma
BNDES Support Program to Develop the Industrial Health Sector
Sistema Único de Saúde (Brasil)
Sistema Único de Saúde (Brazil)
Indústria farmacêutica - Brasil - 2009-2019
Pharmaceutical industry - Brazil - 2009-2019
Biotecnologia farmacêutica - Brasil - 2009-2019
Pharmaceutical biotechnology - 2009-2019
Política industrial - Brasil - 2004-2014
Industrial policy - Brazil - 2004-2014
Política pública
Public policy
Pesquisa e desenvolvimento
Research and development
Issue Date: Mar-2020
Publisher: Banco Nacional de Desenvolvimento Econômico e Social
Abstract: Pharmaceutical biotechnology has created opportunities for the treatment of rare and complex diseases, and has become strategic for innovation policies worldwide, including Brazil. The Brazilian scientific vocation for molecular biology and genomics gave rise to several public policies to internalize specific productive capacity and advance the development of innovative products. The gradual incorporation of those drugs in the Unified Health System (SUS) reinforced the need to spread the use of biosimilars and internalize their production; thus, guaranteeing a stable offer at competitive prices. BNDES contributed to the formulation and application of these policies by financing productive plants and product development; BNDES also participated in collegiate bodies and published articles since 2009. This study aims to analyze the Bank's evolution, focusing on the following axes: public procurement, financing, and regulation.
Other Identifiers: MEIRELLES, Beatriz Barbosa et al. Balanço da estratégia de desenvolvimento da biotecnologia farmacêutica no Brasil: 2009-2019 = Pharmaceutical biotechnology industrial development: an assessment of Brazil’s strategy from 2009 to 2019. BNDES Setorial, Rio de Janeiro, v. 26, n. 51, p. 7-75, mar. 2020.
Appears in Collections:Produção BNDES - Artigos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.